Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for paediatric leukaemia.

R F Rousseau1, C M Bollard, H E Heslop

  • 1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.

Expert Opinion on Biological Therapy
|December 1, 2001
PubMed
Summary

Gene therapy offers promising solutions for pediatric leukemia, addressing chemoresistance and treatment toxicity. Future advancements in gene transfer techniques will significantly impact leukemia treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor.

Leukemia & lymphoma·2016
Same author

Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.

Clinical and experimental immunology·2016
Same author

The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.

Leukemia·2015
Same author

Engineering haploidentical transplants.

Bone marrow transplantation·2015
Same author

Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma.

British journal of cancer·2014
Same author

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD.

Bone marrow transplantation·2014

Area of Science:

  • Pediatric Oncology
  • Molecular Biology
  • Immunology

Background:

  • Chemotherapy and transplant regimens have improved survival rates for pediatric leukemia.
  • Challenges remain, including chemoresistant disease and treatment toxicity.
  • Gene therapy and immunotherapy present promising future treatment avenues.

Purpose of the Study:

  • To explore the role and potential of gene therapy in treating pediatric leukemia.
  • To highlight how gene transfer addresses biological issues in leukemia therapy.
  • To discuss strategies for overcoming treatment resistance and toxicity.

Main Methods:

  • Gene transfer of marker genes to study leukemia biology.
  • Gene marking of autologous bone marrow grafts.
  • Genetic modification of T-cells for allogeneic transplants.
  • Gene transfer to modify tumor function and enhance immunogenicity.

Main Results:

  • Gene marking demonstrated infused marrow's contribution to relapse in myeloid leukemias.
  • Genetically modified T-cells are valuable for viral disease prophylaxis and treatment in allogeneic transplants.
  • Gene transfer strategies are being developed to confer drug-resistance to hematopoietic stem cells.

Conclusions:

  • Gene therapy holds significant promise for improving pediatric leukemia treatment.
  • Gene transfer techniques are crucial for addressing chemoresistance and reducing treatment toxicity.
  • Continued scientific advancements in gene therapy will revolutionize pediatric leukemia care.

Related Experiment Videos